Contract Research

Fusion of Technologies Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan.

The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies

Products with Status Development

Product CAS Specification Status
Everolimus 9003-97-8 In-house Development
Caspofungin Acetate 179463-17-3 In-house Development
Eletriptan HBr 177834-92-3 In-house Development
Temsirolimus 162635-04-3 In-house Development

Products with Status Investigation

Product CAS Specification Status
Micafungin Sodium 208538-73-2 In-house Investigation
Anidulafungin 166663-25-8 In-house Investigation
Zotarolimus 221877-54-9 In-house Investigation
Biolimus 851536-75-9 In-house Investigation